Overview
- 2 inspections across 2 sites are on record.
- 7 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-02-28.
At a glance
Inspections
2
Sites
2
Observations
7
Career since
Jul 2019
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Biomarin Pharmaceutical, Inc. | 28 Feb 2020 | Human Drugs | View 483 → |
| Aveva Drug Delivery Systems Inc. | 26 Jul 2019 | Human Drugs | View 483 → |
Sites inspected
Biomarin Pharmaceutical, Inc.San Rafael, United States1 insp.
Aveva Drug Delivery Systems Inc.Miramar, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Haley H Seymour2 shared
Dustin P Tran1 shared
Stephen T Hansen1 shared
Karen M Montgomery1 shared
Youmin Wang1 shared
Richard A Lyght1 shared
Jennifer Lalama1 shared
Full investigator report
Get the verbatim findings behind Dipti Kalra's 7 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site